zintick

Zymeworks ZYME

Zymeworks Inc. · Nasdaq · Pharmaceutical Preparations

$28.90+0.17%close on Oct. 28, 2026 · volume 833K · Yahoo Finance

Price, last 47 sessions

$26.00$28.00$30.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $31.05 · low $24.77 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Oct. 9, 2026Adam Schayowitz
EVP, Head of R&D
Sold13,832$25.85$357,557

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 6 →
  • 8-KOct. 23, 2026, 6:07 a.m. ETView on SEC.gov

    Entry into a material definitive agreement · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedZymeworks Inc. Licenses ZW209 to Roche for $55.0 Million Upfront, $40.0 Million Phase Ib Payment and Up to $718 Million in Milestones

  • 4Oct. 9, 2026, 6:28 p.m. ETView on SEC.gov
  • 8-KSept. 23, 2026, 4:06 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Completion of acquisition or disposition of assets · Creation of a direct financial obligation · Regulation FD disclosure · Financial statements and exhibits

  • 8-KAug. 25, 2026, 10:54 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

  • 10-QAug. 6, 2026, 4:11 p.m. ETView on SEC.gov
  • 8-KAug. 6, 2026, 4:09 p.m. ETView on SEC.gov

    Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits